Annual ROA
-1108.31%
-991.29%-847.11%
31 December 2023
Summary:
CNS Pharmaceuticals annual return on assets is currently -1108.31%, with the most recent change of -991.29% (-847.11%) on 31 December 2023. During the last 3 years, it has fallen by -1048.65% (-1757.71%). CNSP annual ROA is now -2161.86% below its all-time high of -49.00%, reached on 31 December 2019.CNSP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-515.29%
+267.82%+34.20%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly return on assets is currently -515.29%, with the most recent change of +267.82% (+34.20%) on 30 September 2024. Over the past year, it has dropped by -260.73% (-102.42%). CNSP quarterly ROA is now -395.04% below its all-time high of -104.09%, reached on 30 September 2021.CNSP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -847.1% | -102.4% |
| 3 y3 years | -1757.7% | -395.0% |
| 5 y5 years | -2.5% | +19.9% |
CNSP ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1757.7% | at low | -395.0% | +34.2% |
| 5 y | 5 years | -2161.9% | at low | -395.0% | +34.2% |
| alltime | all time | -2161.9% | at low | -395.0% | +51.7% |
CNS Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -515.29%(-34.2%) |
| June 2024 | - | -783.11%(+36.1%) |
| Mar 2024 | - | -575.35%(+36.5%) |
| Dec 2023 | -1108.31%(+847.1%) | -421.37%(+65.5%) |
| Sept 2023 | - | -254.56%(+32.9%) |
| June 2023 | - | -191.59%(+19.5%) |
| Mar 2023 | - | -160.31%(+33.8%) |
| Dec 2022 | -117.02%(-29.3%) | -119.77%(+4.5%) |
| Sept 2022 | - | -114.66%(+1.0%) |
| June 2022 | - | -113.50%(+1.9%) |
| Mar 2022 | - | -111.43%(-8.4%) |
| Dec 2021 | -165.52% | -121.69%(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -104.09%(-3.3%) |
| June 2021 | - | -107.68%(-12.8%) |
| Mar 2021 | - | -123.48%(-5.2%) |
| Dec 2020 | -59.66%(+21.8%) | -130.29%(-23.5%) |
| Sept 2020 | - | -170.29%(+8.2%) |
| June 2020 | - | -157.40%(+19.9%) |
| Mar 2020 | - | -131.30%(+23.6%) |
| Dec 2019 | -49.00%(-95.5%) | -106.21%(-83.5%) |
| Sept 2019 | - | -643.13%(+0.1%) |
| June 2019 | - | -642.34%(-39.8%) |
| Mar 2019 | - | -1067.42%(+3.0%) |
| Dec 2018 | -1081.79% | -1036.47% |
FAQ
- What is CNS Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual ROA year-on-year change?
- What is CNS Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly ROA year-on-year change?
What is CNS Pharmaceuticals annual return on assets?
The current annual ROA of CNSP is -1108.31%
What is the all time high annual ROA for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual return on assets is -49.00%
What is CNS Pharmaceuticals annual ROA year-on-year change?
Over the past year, CNSP annual return on assets has changed by -991.29% (-847.11%)
What is CNS Pharmaceuticals quarterly return on assets?
The current quarterly ROA of CNSP is -515.29%
What is the all time high quarterly ROA for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly return on assets is -104.09%
What is CNS Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, CNSP quarterly return on assets has changed by -260.73% (-102.42%)